Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation-Reference-Cited by-同舟云学术

Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation

Published:1992-03 Issue:3 Volume:10 Page:206-216
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Hu Xiu-Ti,White Francis J.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference54 articles.

1. Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography

2. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway

3. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats

4. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions

5. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan;Frontiers in Pediatrics;2021-03-04

2. Postsynaptic Mechanisms Render Syn I/II/III Mice Highly Responsive to Psychostimulants;International Journal of Neuropsychopharmacology;2019-04-15

3. Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: An unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms;Behavioural Brain Research;2009-12

4. Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism;Neurobiology of Disease;2005-04

5. Actions of the D 1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L -dopa-primed common marmosets;Psychopharmacology;1999-02-18